Treating The Common Cold An Expert Panel Consensus Recommendation for Primary Care Clinicians

Faculty Disclosure

Faculty are required to disclose to program participants any relationship, including financial interest or affiliation(s), with a commercial company, as well as discussion of unlabeled uses.

The IAFP and FnP Associates adhere to the conflict of interest policy of the American Academy of Family Physicians and American Nurses Credentialing Center, respectively, as well as to the guidelines of the Accreditation Council for Continuing Medical Education and the American Medical Association. Current guidelines state that participants in CME activities should be made aware of any affiliation or financial interest that may affect an author's article. Authors of this guideline have completed conflict of interest statements. Disclosures do not suggest bias but provide readers with information relevant to evaluation of the guideline contents.

Tim R. Covington, MS, PharmD reports a current consulting agreement with ACIP-CO, Inc.; current financial interest/stock ownership in TIAA/CREF retirement portfolio, and research funding sources including Strategic Health Partners and Blue Cross/Blue Shield of Alabama. Robert Henkin, MD, PhD reports a current consulting agreement with The Quigley Corporation. Wendy Wright, MS, FNP reports serving on the speaker bureaus of the following companies: Pfizer, EXACT Sciences, Aventis, GlaxoSmithKline, AstraZeneca, and McNeil Consumer, and Specialty Pharmaceuticals. Shelley Miller, MMS, PA-C and Marion Sassetti, MD report no device or drug company affiliations that could represent potential conflicts of interest.

This guideline does not include any discussion or demonstration of any pharmaceuticals or medical devices that are not approved by the Food and Drug Administration (FDA) or that are considered "off-label".